Disclosures for "Patient Characteristics and Real-world Use of Botulinum Toxins for Treatment of Chronic Sialorrhea "
-
Michael Hast has received personal compensation for serving as an employee of Merz.
-
Dr. Kong has received personal compensation for serving as an employee of Aetion. Dr. Kong has stock in Aetion. The institution of Dr. Kong has received research support from Merz.
-
Miss Abdelhadi has received personal compensation for serving as an employee of Aetion. Miss Abdelhadi has stock in Aetion.
-
Mr. Szendrey has received personal compensation for serving as an employee of Aetion, Inc.
-
The institution of Mr. Shah has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Merz. Mr. Shah has stock in Aetion. The institution of Mr. Shah has received research support from Merz.
-
Dr. Holmes has received personal compensation for serving as an employee of Merz Therapeutics.